endocrine/exocrine glands
• in 4 of 24 mice
|
mortality/aging
• median survival is 12 months
|
neoplasm
• hepatic adenomas in 2 of 29 mice
|
• in 1 of 29 mice
|
• seen in 90% (26/29) of mice
|
• in 4 of 24 mice
|
• seen in 83% (20/24) of mice
|
• uterine adenocarcinoma in 1 of 29 mice
|
• in 5 of 29 mice
|
liver/biliary system
• hepatic adenomas in 2 of 29 mice
|
cellular
• increase in microsatellite instability and mutation frequencies
|
• absence of MMR in MEFs
|
immune system
• in 4 of 24 mice
|
• decrease in ex vivo class switch recombination
|
reproductive system
N |
• in contrast to homozygous null males, males are fertile with normal spermatogenesis and normal testis size
|
hematopoietic system
• in 4 of 24 mice
|
• decrease in ex vivo class switch recombination
|
homeostasis/metabolism
• increase in microsatellite instability and mutation frequencies
|
• absence of MMR in MEFs
|